Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 8, 2006

Andrew von Eschenbach Voted Chief of FDA

  • The Senate voted Andrew von Eschenbach, M.D., chief of the FDA. Senators supported his nomination by a vote of 80 to 11. This decision comes after slightly over a year of Dr. von Eschenbach serving as acting head of the FDA. During that time he erased a major obstacle to his confirmation by allowing access to Plan B, the morning after pill, without a prescription.

    “It is critical that the FDA again be the gold standard of drug approval,” Senator Hillary Clinton in her official statement. “By making a long overdue decision on Plan B, Dr. von Eshenbach showed encouraging signs that he will take seriously the FDA’s responsibility to put science over ideology."



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »